Technology
Health
Pharmaceutical
Arcturus Therapeutics Holdings
$11.609876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$11.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.77 (7.10%) Today
-$0.02 (-0.17%) As of 4:02 PM EDT after-hours
Why Robinhood?
You can buy or sell ARCT and other stocks, options, ETFs, and crypto commission-free!
About ARCT
Arcturus Therapeutics Holdings, Inc. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. Read More The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA.
Employees
—
Headquarters
San Diego, California
Founded
2013
Market Cap
115.44M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
70.91K
High Today
$11.85
Low Today
$10.99
Open Price
$10.99
Volume
249.76K
52 Week High
$11.85
52 Week Low
$4.11
Collections
Technology
Health
Pharmaceutical
Therapy
2013 IPO
US
North America
Analyst Ratings
100%
of 6 ratings
Buy
100%
Hold
0%
Sell
0%
ARCT Earnings
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 8, After Hours